DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Houede N, Beuzeboc P, Gourgou S. et al.
Abiraterone acetate in patients with metastatic castration-resistant prostate cancer: long term outcome of the Temporary Authorization for Use programme in France.
BMC Cancer 2015;
15: 222
DOI: 10.1186/s12885-015-1257-2.
We do not assume any responsibility for the contents of the web pages of other providers.